Skip to search formSkip to main contentSkip to account menu

Plerixafor Injection [Mozobil]

National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

1.2 ML Plerixafor 20 MG/ML Injection [Mozobil]
InjectionMozobil

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
CP-010 Use and effectiveness of plerixafor for haematopoietic stem cells mobilisation
Background Plerixafor is an immunostimulant used in combination with granulocyte–colony stimulating factor (G-CSF) to mobilise… 
2014
2014
Peripheral Blood Progenitor Cells Mobilization in Patients with Multiple Myeloma
Autologous stem cell transplantation (ASCT) is considered the standard therapy for younger patients with newly diagnosed… 
2010
2010
Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil ® ) + G-CSF In Pediatric Patients with Malignant Disorders
Abstract 2245 Background: High dose chemo/radiotherapy followed by autologous hematopoietic stem cell (HSC) transplantation (HSCT… 
2009
2009
Similar 1 Year Survival of Patients Receiving Plerixafor (Mozobil*®) Plus G-CSF Versus Placebo Plus G-CSF Mobilized Autologous Grafts: Results From Two Phase 3 Randomized Trials in Patients with NHL…
Abstract 2319 Poster Board II-296 Background: Data from two phase 3 clinical trials indicate that plerixafor plus G-CSF is safe… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)